Antiplatelet brokers involve aspirin, aspirin furthermore dipyridamole, ticlopidine, and clopidogrel. They avoid clots from forming by holding blood cells and platelets from clumping together. They may be given to help reduce coronary heart assault and stroke. Structural abnormalities: In some cases irregularities inside the blood vessel anatomy can cause narrowing, https://www.sgvascularctr.com/types-of-treatments-for-vascular-diseases/